Company: SNWV
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001628280-25-050280
Chunk: 66

Company: SANUWAVE Health, Inc.
Filing Date: 2025-11-06
Form: 10-Q
Item: Part I, Item 1
Chunk 66
---
 Marketing

Selling and marketing expenses for the three months ended September 30, 2025, were $2.1 million as compared to $2.2 million for the same period of 2024, a decrease of $0.1 million, or 5%. The year-over-year decrease in sales and marketing expenses in the three months ended September 30, 2025, was primarily due to a decrease of $1.0 million in outside commission expense, partially offset by an increase in headcount expenses of $0.8 million.

Selling and marketing expenses for the nine months ended September 30, 2025, were $5.3 million as compared to $4.5 million for the same period of 2024, an increase of $0.8 million, or 18%. The year-over-year increase in sales and marketing expenses for the nine months ended September 30, 2025, was primarily due to increased headcount expenses of $2.2 million, partially offset by a decrease in outside commission expense of $1.3 million.

Research and Development

Research and development expenses for the three months ended September 30, 2025 were $0.3 million compared to $0.2 million for the three months ended September 30, 2024. The research and development costs in the three months ended September 30, 2025, remained approximately consistent with the costs in the same period of 2024.

Research and development expenses for the nine months ended September 30, 2025 were $0.7 million compared to $0.5 million for the nine months ended September 30, 2024. The research and development costs in the nine months ended September 30, 2025, remained approximately consistent with the costs in the same period of 2024.

27

Total Other Income (Expense)

Other income (expense) consists of the following:

Three Months Ended September 30,ChangeNine Months Ended September 30,Change20252024$%20252024$%Interest expense$(1,722)$(3,661)$1,939 53%$(5,448)$(11,004)$5,556 50%Change in fair value of derivative liabilities6,097 (18,849)24,946 132%2,186 (17,633)19,819 112%Gain (Loss) on extinguishment of debt(477)- (477)-%(477)5,205